DK573274A - - Google Patents

Info

Publication number
DK573274A
DK573274A DK573274A DK573274A DK573274A DK 573274 A DK573274 A DK 573274A DK 573274 A DK573274 A DK 573274A DK 573274 A DK573274 A DK 573274A DK 573274 A DK573274 A DK 573274A
Authority
DK
Denmark
Application number
DK573274A
Other languages
Danish (da)
Other versions
DK136719C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
DK136719B (da
Inventor
R A Archer
Original Assignee
Lilly E And Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly E And Co filed Critical Lilly E And Co
Publication of DK573274A publication Critical patent/DK573274A/da
Publication of DK136719B publication Critical patent/DK136719B/da
Application granted granted Critical
Publication of DK136719C publication Critical patent/DK136719C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DK573274AA 1973-11-05 1974-11-04 Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner. DK136719B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (3)

Publication Number Publication Date
DK573274A true DK573274A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-07-07
DK136719B DK136719B (da) 1977-11-14
DK136719C DK136719C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-04-24

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
DK573274AA DK136719B (da) 1973-11-05 1974-11-04 Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner.

Country Status (26)

Country Link
US (1) US3968125A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6033835B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR202318A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT336012B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE821716A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG26387A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1023753A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH605894A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS193507B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD116230A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2451934C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK136719B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES431674A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2249664B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1487637A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU169193B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE40023B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL45644A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7414439A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH11788A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL95748B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (1) RO71766A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE415762B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU524517A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU36515B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA745751B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
JPWO2003070277A1 (ja) * 2002-02-19 2005-06-09 塩野義製薬株式会社 抗掻痒剤
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
MX2010001242A (es) * 2007-07-30 2010-07-02 Alltranz Inc Profarmacos de canabidiol, composiciones que comprenden profarmacos de canabidiol y metodos para utilizar los mismos.
JP5704925B2 (ja) 2008-02-08 2015-04-22 ウェルズ ファーゴ バンク ナショナル アソシエイション オリゴマー−カンナビノイドコンジュゲート
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR101741629B1 (ko) 2009-05-06 2017-05-31 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP3654942A1 (en) 2017-07-20 2020-05-27 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Pharmaceutical film compositions for delivery of lipophilic compounds into and/or across the skin
EP3681474A1 (en) 2017-09-11 2020-07-22 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Compositions and methods for nasal administration of drugs to brain and for systemic effect
EP3717014A1 (en) 2017-11-29 2020-10-07 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Cannabinoids compositions and methods
WO2020089905A1 (en) 2018-11-04 2020-05-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Orally administrable cannabinoids-containing compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
IL45644A0 (en) 1974-11-29
HU169193B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-10-28
AR202318A1 (es) 1975-05-30
SE7413833L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-05-06
US3968125A (en) 1976-07-06
AU7321274A (en) 1976-03-18
ZA745751B (en) 1976-04-28
RO71766A (ro) 1982-12-06
DE2451934C2 (de) 1983-10-06
PL93908B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-07-30
IE40023L (en) 1975-05-05
PH11788A (en) 1978-07-05
DD116230A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-11-12
CH605894A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-10-13
YU36515B (en) 1984-02-29
JPS5071678A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-06-13
SE415762B (sv) 1980-10-27
ES431674A1 (es) 1976-11-16
GB1487637A (en) 1977-10-05
FR2249664A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-05-30
CA1023753A (en) 1978-01-03
DE2451934A1 (de) 1975-05-07
YU265874A (en) 1982-02-25
IE40023B1 (en) 1979-02-28
CS193507B2 (en) 1979-10-31
BE821716A (fr) 1975-04-30
JPS6033835B2 (ja) 1985-08-05
DK136719C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-04-24
SU524517A3 (ru) 1976-08-05
IL45644A (en) 1978-03-10
PL95748B1 (pl) 1977-11-30
ATA886374A (de) 1976-08-15
DK136719B (da) 1977-11-14
AT336012B (de) 1977-04-12
NL7414439A (nl) 1975-05-07
BG26387A3 (bg) 1979-03-15
FR2249664B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-03-24

Similar Documents

Publication Publication Date Title
AR201758A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR201235Q (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR201231Q (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK136719C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR201229Q (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR199451A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU477823B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR210729A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR197627A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR196382A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR200256A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR201432A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU477824B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR200885A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR196212Q (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH567551A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH561548A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH561614A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH38774A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH562523A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH562524A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH563303A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG20168A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG19319A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU480973A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
PBP Patent lapsed